BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17362320)

  • 1. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis.
    Chia VM; Newcomb PA; Trentham-Dietz A; Hampton JM
    Int J Gynecol Cancer; 2007; 17(2):441-6. PubMed ID: 17362320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients.
    Arem H; Park Y; Pelser C; Ballard-Barbash R; Irwin ML; Hollenbeck A; Gierach GL; Brinton LA; Pfeiffer RM; Matthews CE
    J Natl Cancer Inst; 2013 Mar; 105(5):342-9. PubMed ID: 23297041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
    Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
    Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.
    Felix AS; Scott McMeekin D; Mutch D; Walker JL; Creasman WT; Cohn DE; Ali S; Moore RG; Downs LS; Ioffe OB; Park KJ; Sherman ME; Brinton LA
    Gynecol Oncol; 2015 Oct; 139(1):70-6. PubMed ID: 26341710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and age at diagnosis of endometrial cancer.
    Nevadunsky NS; Van Arsdale A; Strickler HD; Moadel A; Kaur G; Levitt J; Girda E; Goldfinger M; Goldberg GL; Einstein MH
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):300-306. PubMed ID: 25004350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes, body size, and risk of endometrial cancer.
    Shoff SM; Newcomb PA
    Am J Epidemiol; 1998 Aug; 148(3):234-40. PubMed ID: 9690359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
    Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
    Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-diagnosis body mass index and mortality among women diagnosed with endometrial cancer: Results from the Women's Health Initiative.
    Arem H; Pfeiffer RM; Moore SC; Irwin ML; LaMonte MJ; Sarto GE; Nassir R; Luo J; Chlebowski RT; Brinton LA; Matthews CE
    PLoS One; 2017; 12(2):e0171250. PubMed ID: 28152055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.
    Saltzman BS; Doherty JA; Hill DA; Beresford SA; Voigt LF; Chen C; Weiss NS
    Am J Epidemiol; 2008 Mar; 167(5):607-14. PubMed ID: 18071194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
    Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
    Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based study of causes of death after endometrial cancer according to major risk factors.
    Lees B; Hampton JM; Trentham-Dietz A; Newcomb P; Spencer R
    Gynecol Oncol; 2021 Mar; 160(3):655-659. PubMed ID: 33422300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
    Nagle CM; Crosbie EJ; Brand A; Obermair A; Oehler MK; Quinn M; Leung Y; Spurdle AB; Webb PM;
    Gynecol Oncol; 2018 Jul; 150(1):99-105. PubMed ID: 29706522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the percentage of body fat on surgical, clinical and pathological outcomes in women with endometrial cancer.
    Kerimoglu OS; Pekin A; Yilmaz SA; Yavas G; Beyhekim F; Demirtaş AA; Dogan NU; İlhan TT; Celik C
    J Obstet Gynaecol Res; 2015 Mar; 41(3):449-55. PubMed ID: 25330937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node status did not significantly improve the predictability of survival in patients with clinically early-stage endometrial cancer.
    Bae HS; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT; Kang S
    Int J Gynecol Cancer; 2014 Oct; 24(8):1449-54. PubMed ID: 25180462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden).
    Weiderpass E; Persson I; Adami HO; Magnusson C; Lindgren A; Baron JA
    Cancer Causes Control; 2000 Feb; 11(2):185-92. PubMed ID: 10710204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey.
    Lindemann K; Cvancarova M; Eskild A
    Gynecol Oncol; 2015 Dec; 139(3):476-80. PubMed ID: 26434365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.